Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation

The use of totally implantable venous access devices developed as a medical device allowing mid- and long-term, frequent, repeated, or continuous injection of therapeutic products, by vascular, cavitary, or perineural access. The effective flushing of these devices is a central element to assure long-lasting use. Our experimental work demonstrates that directing the Huber point needle opening in the diametrically opposite direction of the implantable port exit channel increases the flushing efficiency. These results are consolidated by numerical computations, which support recommendations not only for their maintenance, but also for their use.

[1]  G. Guiffant,et al.  Flushing of Intravascular Access Devices (IVADs) - Efficacy of Pulsed and Continuous Infusions , 2012, The journal of vascular access.

[2]  Tomohiro Matsumoto,et al.  Use of N-butyl cyanoacrylate in implantation of a port-catheter system for hepatic arterial infusion chemotherapy with the fixed-catheter-tip method: is it necessary? , 2008, AJR. American journal of roentgenology.

[3]  I. Campbell,et al.  Fibronectin structure and assembly. , 1994, Current opinion in cell biology.

[4]  C. Pui,et al.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters , 2009, The Lancet.

[5]  T. Nishimura,et al.  Brain infarction after percutaneous implantation of port-catheter system via the left subclavian artery. , 2002, The British journal of radiology.

[6]  Z. Samra,et al.  Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. , 2006, The Journal of hospital infection.

[7]  P. Hall,et al.  Implantable catheter system for long‐term intravenous chemotherapy , 1989, Journal of surgical oncology.

[8]  G. Guiffant,et al.  The use of a hydrodynamic bench for experimental simulation of flushing venous catheters: impact on the technique , 2005 .

[9]  Hugues Berry,et al.  Adsorption-induced fibronectin aggregation and fibrillogenesis. , 2006, Journal of colloid and interface science.

[10]  M. Joudi,et al.  STUDY OF ADVANTAGES AND DISADVANTAGES OF TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE , 2006 .

[11]  J. Macfie,et al.  ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). , 2009, Clinical nutrition.

[12]  D. Brambilla,et al.  Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  Thomas A. Horbett,et al.  The role of adsorbed proteins in animal cell adhesion , 1994 .

[14]  H. Sittek,et al.  Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. , 2000, Radiology.

[15]  T. Nishimura,et al.  Management of end hole in placement of port-catheter system for continuous hepatic arterial infusion chemotherapy using the fixed catheter tip method. , 2005, AJR. American journal of roentgenology.